X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1775) 1775
linezolid (1366) 1366
oxazolidinones - therapeutic use (1332) 1332
acetamides - therapeutic use (1029) 1029
male (822) 822
female (727) 727
pharmacology & pharmacy (720) 720
anti-bacterial agents - therapeutic use (688) 688
microbiology (579) 579
infectious diseases (564) 564
middle aged (529) 529
adult (493) 493
oxazolidinones - pharmacology (470) 470
vancomycin (404) 404
aged (400) 400
anti-infective agents - therapeutic use (387) 387
treatment outcome (387) 387
oxazolidinones - adverse effects (380) 380
oxazolidinones (362) 362
microbial sensitivity tests (351) 351
acetamides - pharmacology (347) 347
staphylococcal infections - drug therapy (346) 346
animals (339) 339
oxazolidinones - administration & dosage (335) 335
anti-bacterial agents - pharmacology (325) 325
gram-positive bacterial infections - drug therapy (282) 282
acetamides - adverse effects (274) 274
infections (259) 259
vancomycin - therapeutic use (256) 256
acetamides - administration & dosage (243) 243
antibiotics (241) 241
pharmacokinetics (230) 230
oxazolidinones - pharmacokinetics (229) 229
staphylococcus aureus (202) 202
staphylococcal infections - microbiology (201) 201
staphylococcus aureus - drug effects (196) 196
migraine disorders - drug therapy (191) 191
adolescent (184) 184
methicillin resistance (179) 179
oxazolidinone (177) 177
tryptamines (170) 170
serotonin receptor agonists - therapeutic use (169) 169
efficacy (167) 167
drug therapy (165) 165
acetamides - pharmacokinetics (164) 164
resistant staphylococcus-aureus (162) 162
methicillin-resistant staphylococcus aureus - drug effects (157) 157
drug resistance, bacterial (156) 156
health aspects (153) 153
anti-bacterial agents - adverse effects (152) 152
gram-positive bacterial infections - microbiology (149) 149
anti-bacterial agents - administration & dosage (145) 145
drug therapy, combination (144) 144
retrospective studies (138) 138
aged, 80 and over (137) 137
drug resistance (137) 137
immunology (134) 134
internal medicine (132) 132
drug resistance in microorganisms (131) 131
methicillin-resistant staphylococcus aureus (129) 129
pneumonia (129) 129
double-blind (126) 126
infectious disease (126) 126
oxazoles - therapeutic use (123) 123
safety (123) 123
clinical neurology (121) 121
migraine (121) 121
cross infection - drug therapy (120) 120
time factors (119) 119
administration, oral (118) 118
anti-infective agents - adverse effects (118) 118
staphylococcus-aureus (118) 118
therapy (118) 118
medicine, general & internal (116) 116
vancomycin resistance (115) 115
anti-bacterial agents - pharmacokinetics (114) 114
care and treatment (113) 113
double-blind method (111) 111
biochemical phenomena, metabolism, and nutrition (110) 110
anti-infective agents - pharmacology (107) 107
analysis (106) 106
zolmitriptan (106) 106
bacteria (105) 105
in-vitro activities (105) 105
young adult (105) 105
daptomycin - therapeutic use (103) 103
dose-response relationship, drug (103) 103
daptomycin (101) 101
mice (101) 101
medicine & public health (100) 100
research (97) 97
risk factors (97) 97
child (95) 95
antibacterial agents (93) 93
bacteremia (92) 92
mrsa (92) 92
vancomycin - pharmacology (92) 92
antitubercular agents - therapeutic use (91) 91
drug resistance, multiple, bacterial (91) 91
in-vitro activity (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1972) 1972
Spanish (42) 42
French (35) 35
German (29) 29
Japanese (22) 22
Russian (16) 16
Italian (10) 10
Chinese (8) 8
Turkish (8) 8
Portuguese (7) 7
Czech (4) 4
Polish (3) 3
Bulgarian (2) 2
Dutch (2) 2
Finnish (2) 2
Hungarian (2) 2
Romanian (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2003, Volume 63, Issue 16, 41
The trigeminal autonomic cephalgias (TACs) are a group of primary headache disorders characterised by unilateral trigeminal distribution pain that occurs in... 
Methysergide, therapeutic use | Headache, treatment | Antiepileptic drugs, therapeutic use | Capsaicin, therapeutic use | Antimigraines, therapeutic use | Research and development | Cluster headache, treatment | Oxygen inhalation therapy | Leuprorelin, therapeutic use | Somatostatin, therapeutic use | Local anaesthetics, therapeutic use | Surgery | Civamide, therapeutic use | Clonidine, therapeutic use | Dihydroergotamine mesylate, therapeutic use | Nimodipine, therapeutic use | Lidocaine, therapeutic use | Calcium channel antagonists, therapeutic use | Methylergometrine, therapeutic use | Olanzapine, therapeutic use | Nerve block | Zolmitriptan, therapeutic use | Dehydroemetine, therapeutic use | Valproic acid, therapeutic use | Migraine, treatment | Baclofen, therapeutic use | Melatonin, therapeutic use | Lithium, therapeutic use | Verapamil, therapeutic use | Ergotamine, therapeutic use | Chlorpromazine, therapeutic use | Serotonin 1D receptor agonists, therapeutic use | Sumatriptan, therapeutic use | Cocaine, therapeutic use | Analgesics, therapeutic use | Pizotifen, therapeutic use | Corticosteroids, therapeutic use | Gabapentin, therapeutic use | Topiramate, therapeutic use | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | SUNCT SYNDROME | CONJUNCTIVAL INJECTION | PROPHYLACTIC TREATMENT | PHARMACOLOGY & PHARMACY | TOXICOLOGY | UNILATERAL NEURALGIFORM HEADACHE | PLACEBO-CONTROLLED TRIAL | LITHIUM-CARBONATE | BRAIN-STEM ACTIVATION | MIGRAINOUS NEURALGIA | CHRONIC PAROXYSMAL HEMICRANIA | EPISODIC CLUSTER HEADACHE | Analgesics - pharmacology | Analgesics - therapeutic use | Ergot Alkaloids - pharmacology | Oxygen - pharmacology | Drug Administration Schedule | Humans | Sumatriptan - therapeutic use | Trigeminal Neuralgia - diagnosis | Trigeminal Neuralgia - physiopathology | Vascular Headaches - diagnosis | Male | Anesthetics, Local - pharmacology | Oxazolidinones - therapeutic use | Vascular Headaches - physiopathology | Sumatriptan - pharmacology | Oxazolidinones - pharmacology | Trigeminal Neuralgia - drug therapy | Ergot Alkaloids - therapeutic use | Female | Anesthetics, Local - therapeutic use | Tryptamines | Vascular Headaches - drug therapy
Book Review
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SOFT-TISSUE INFECTIONS | DOSE PHARMACOKINETICS | CLINICAL-TRIAL | ANTIBACTERIAL ACTIVITY | MOUSE MODEL | ECONOMIC OUTCOMES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LENGTH-OF-STAY | MURINE THIGH INFECTION | COMPLICATED SKIN | TRIMETHOPRIM-SULFAMETHOXAZOLE | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2006, Volume 50, Issue 6, pp. 1921 - 1926
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
BACTERICIDAL ACTIVITY | SAFETY | NITROIMIDAZOPYRAN PA-824 | TUBERCULOSIS | SUSCEPTIBILITY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INFECTION | COMBINATION | Fluoroquinolones | Linezolid | Aza Compounds - therapeutic use | Colony Count, Microbial | Moxifloxacin | Oxazolidinones - administration & dosage | Quinolines - administration & dosage | Oxazolidinones - therapeutic use | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Mycobacterium ulcerans - growth & development | Nitroimidazoles - therapeutic use | Acetamides - therapeutic use | Time Factors | Mycobacterium Infections, Nontuberculous - microbiology | Female | Rifampin - therapeutic use | Rifampin - administration & dosage | Nitroimidazoles - administration & dosage | Streptomycin - administration & dosage | Aza Compounds - administration & dosage | Anti-Infective Agents - therapeutic use | Mycobacterium ulcerans - drug effects | Mycobacterium Infections, Nontuberculous - mortality | Foot - microbiology | Amikacin - administration & dosage | Amikacin - therapeutic use | Animals | Streptomycin - therapeutic use | Survival Analysis | Diarylquinolines | Mice | Mice, Inbred BALB C | Quinolines - therapeutic use | In Vitro Techniques | Mycobacterium Infections, Nontuberculous - drug therapy | Acetamides - administration & dosage | Experimental Therapeutics
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2012, Volume 56, Issue 6, pp. 3114 - 3120
Journal Article
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9656, pp. 2115 - 2123
Journal Article